Abcentra
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Focused Orticumab Research for Treating Inflammation in Coronary Arteries Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation | Phase 2 | 2025-08-11 |
| Completed | A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors Psoriasis, Inflammation, Coronary Artery Disease | Phase 2 | 2021-06-30 |